The Evolutionary Landscape of Treatment for BRAF(V600E) Mutant Metastatic Colorectal Cancer

SIMPLE SUMMARY: The BRAF(V600E) mutation accounts for 8–10% of metastatic colorectal cancer (mCRC) patients and it is an established prognostic factor. Median overall survival of this subset of patients is indeed so poor that it is similar to first line PFS of patients without this molecular alterat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Mauri, Gianluca, Bonazzina, Erica, Amatu, Alessio, Tosi, Federica, Bencardino, Katia, Gori, Viviana, Massihnia, Daniela, Cipani, Tiziana, Spina, Francesco, Ghezzi, Silvia, Siena, Salvatore, Sartore-Bianchi, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795863/
https://ncbi.nlm.nih.gov/pubmed/33406649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados